Forge Biologics
The Manager, Document Control leads the Document Control team in a GMP‑regulated environment, overseeing the issuance, maintenance, and lifecycle of controlled documents using an electronic quality management system. This role ensures compliance, supports manufacturing and quality functions, and drives continuous improvement through cross‑functional collaboration and regulatory readiness.
Headquarters
Columbus, Ohio, United States
Company Size
201-500 employees
Founded
2020
Forge Biologics is a CDMO focused on accelerating gene therapy manufacturing, specializing in high‑yield adeno‑associated virus (AAV) vector production. The company offers end‑to‑end services including process and analytical development, clinical‑to‑commercial cGMP manufacturing at a world‑class facility, and regulatory and supply‑chain support. Clients partner with Forge for scalable AAV capacity, technical expertise, and seamless program support to move therapies faster toward patients.
Forge Biologics Emphasizes Safety Culture and EHSS Leadership
24 hours ago
The Progeria Research Foundation and Forge Biologics Announce Manufacturing Partnership to Advance Gene Therapy for Children with Progeria
1 week ago
May the Forge be with you: Ascidian partners with Forge Biologics to tackle Stargardt disease
Jan 13, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Forge Biologics.
Forge Biologics didn’t post a salary, so this is our estimate from similar listings.
8% below the average for this role
Ascidian Therapeutics, Forge Biologics Partner to Advance Stargardt Treatment
Jan 7, 2026